Defining the immunoglobulin (Ig) switch to IgE in glycan-specific B cell responses using the model disease of anaphylaxis to galactose-alpha-1,3-galactose

使用半乳糖-α-1,3-半乳糖过敏模型疾病定义聚糖特异性 B 细胞反应中免疫球蛋白 (Ig) 向 IgE 的转变

基本信息

项目摘要

Up to now, carbohydrate-specific immune responses are insufficiently understood. In the scope of this proposal, we investigate the immunological mechanisms of carbohydrate-specific B cell responses using the model antigen galactose-alpha-1,3-galactose ("alpha-gal"). Alpha-is ubiquitously expressed and all mammals except of old-world monkeys and humans express this carbohydrate. Consequently, alpha-gal is recognized as non-self by the latter and it is known that after tick bites, alpha-gal specific IgE antibodies can be induced potentially eliciting life-threatening allergic reactions upon contact with alpha-gal expressing drugs or red meat. Interestingly, a substantial amount of alpha-gal specific IgM and IgG is present in all humans independent of this type of alpha-gal sensitization and is believed to contribute to the protection e.g. against parasite infections and to belong to the pool of ‘natural’ antibodies derived from B-1 cells. For more detailed investigations, we established a mouse model in which alpha-gal specific IgE antibodies and anaphylaxis after alpha-gal exposure develop upon percutaneous sensitization to alpha-gal. Using this model, however, we could show an expansion of alpha-gal specific B-2 cells as well as germinal center B cells with dominant IgG1 but absent IgE expression, indicating for the first time that carbohydrate-specific IgE responses arise through sequential class switching involving an IgG1 intermediate stage. Following up on these observations, we will perform in-depth analysis of alpha-gal specific B cells and, among others, decipher the role of specific B cell populations using transfer into B cell deficient mice. B cell receptor repertoire analyses and ex vivo class switching approaches of different isotypes in the mouse model as well as in alpha-gal allergic patients and controls will be used to elucidate the generation of alpha-gal IgE via an IgG1 intermediate stage. In the second part of the proposal, we will for the first time investigate the role of type 2 immunity in carbohydrate antigen, in our case alpha-gal, induced IgE class switching. To this end, we will use IL-4 reporter mice to decipher the type 2 immune cascade using single-cell RNA sequencing. The role of follicular and type 2 helper T cells in alpha-gal specific IgE responses and anaphylaxis will be investigated using adoptive transfer of T cell subsets into T cell deficient mice. In summary, this project will help us to decipher the so far insufficiently understood immunological mechanisms underlying high affinity carbohydrate-specific humoral immune responses
到目前为止,对碳水化合物特异性免疫反应的了解还不够充分。在本提案的范围内,我们使用模型抗原半乳糖- α -1,3-半乳糖(“α -gal”)研究碳水化合物特异性B细胞反应的免疫学机制。α -是普遍表达的,除了旧世界的猴子和人类,所有哺乳动物都表达这种碳水化合物。因此,α -gal被后者识别为非自我,并且已知在蜱虫叮咬后,α -gal特异性IgE抗体可被诱导,在接触表达α -gal的药物或红肉时可能引发危及生命的过敏反应。有趣的是,大量的α -半乳糖特异性IgM和IgG存在于所有人类中,独立于这种类型的α -半乳糖致敏,被认为有助于防止寄生虫感染,属于来自B-1细胞的“天然”抗体池。为了进行更详细的研究,我们建立了一个小鼠模型,其中α -半乳糖特异性IgE抗体和α -半乳糖经皮致敏后暴露后的过敏反应。然而,使用该模型,我们可以显示α -半乳糖特异性B-2细胞和生发中心B细胞的扩增,其中IgG1占主导地位,但缺乏IgE表达,这首次表明碳水化合物特异性IgE反应是通过涉及IgG1中间阶段的顺序类转换产生的。根据这些观察结果,我们将对α -半乳糖特异性B细胞进行深入分析,并通过将其转移到B细胞缺陷小鼠中来破译特定B细胞群的作用。在小鼠模型以及α -半乳糖过敏患者和对照组中,B细胞受体库分析和不同同型的离体类转换方法将用于阐明通过IgG1中间阶段产生α -半乳糖IgE。在提案的第二部分,我们将首次研究2型免疫在碳水化合物抗原(在我们的案例中是α -gal)诱导的IgE类转换中的作用。为此,我们将使用IL-4报告小鼠使用单细胞RNA测序来破译2型免疫级联。滤泡和2型辅助性T细胞在α -半乳糖特异性IgE反应和过敏反应中的作用将通过T细胞亚群过继转移到T细胞缺陷小鼠中进行研究。总之,该项目将帮助我们破译到目前为止尚未充分理解的高亲和力碳水化合物特异性体液免疫反应的免疫学机制

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Professor Dr. Tilo Biedermann其他文献

Professor Dr. Tilo Biedermann的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Professor Dr. Tilo Biedermann', 18)}}的其他基金

Targeting Key Factors Involved in Immune Reactions mediated by Tick Bites to the Carbohydrate alpha-Gal
将蜱虫叮咬介导的免疫反应中涉及的关键因素靶向碳水化合物 α-Gal
  • 批准号:
    392344742
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
    Research Grants
TLR2 activation underlying immune regulation at interfaces
TLR2 激活是界面免疫调节的基础
  • 批准号:
    212173602
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Programme coordination and instruments to achieve the structural goals of the priority programme
实现优先计划结构性目标的计划和协调工具
  • 批准号:
    125501409
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
    Priority Programmes
The role of mast cell MHC II in tumor immunosurveillance
肥大细胞MHC II在肿瘤免疫监视中的作用
  • 批准号:
    124457661
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
    Priority Programmes
Mechanismen der Modulation Allergen-spezifischer Aktivierung durch Signale der natürlichen Immunität
自然免疫信号调节过敏原特异性激活的机制
  • 批准号:
    21808282
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
    Research Grants

相似海外基金

Human Plasma Cell Maturation & Maintenance through CD138, TNFRSF, and Modulation of Ig Secretion
人类浆细胞成熟
  • 批准号:
    10660723
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
AAV-mediated delivery of eCD4-Ig for prevention and treatment of perinatal HIV infection
AAV 介导的 eCD4-Ig 递送用于预防和治疗围产期 HIV 感染
  • 批准号:
    10082720
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
AAV-mediated delivery of eCD4-Ig for prevention and treatment of perinatal HIV infection
AAV 介导的 eCD4-Ig 递送用于预防和治疗围产期 HIV 感染
  • 批准号:
    10406312
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
eCD4-Ig for preventing and treating obstetric HIV infection
eCD4-Ig 用于预防和治疗产科 HIV 感染
  • 批准号:
    10238165
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
eCD4-Ig for preventing and treating obstetric HIV infection
eCD4-Ig 用于预防和治疗产科 HIV 感染
  • 批准号:
    10082182
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
eCD4-Ig for preventing and treating obstetric HIV infection
eCD4-Ig 用于预防和治疗产科 HIV 感染
  • 批准号:
    10415989
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig
改善 eCD4-Ig 的药代动力学、效力和免疫原性
  • 批准号:
    10394340
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Identifying the Ig domain of titin interacting with filamin and analyzing its mutation
鉴定与细丝蛋白相互作用的肌联蛋白 Ig 结构域并分析其突变
  • 批准号:
    406347
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
    Studentship Programs
Development of AAV vectors for long-term expression of eCD4-Ig
开发用于长期表达 eCD4-Ig 的 AAV 载体
  • 批准号:
    9770769
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Defining the Transcriptional Regulation and Genomic Organization of FAIM3 and PIGR, Human Ig Receptors Involved in Immunity, Auto-Immune Disease, and Lymphoma
定义 FAIM3 和 PIGR、参与免疫、自身免疫性疾病和淋巴瘤的人类 Ig 受体的转录调控和基因组组织
  • 批准号:
    9395470
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了